Related Experiment Video
Updated: May 17, 2026
11:06
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Understanding pharmacokinetic food effects using molecular dynamics simulation coupled with physiologically based
David C Turner1, Fuchang Yin, James T Kindt
1Department of Pharmaceutical Sciences, Mercer University, Atlanta, GA 30341, USA.
Biopharmaceutics & Drug Disposition
|October 16, 2012
Summary
Molecular dynamics simulations enhance drug absorption modeling by predicting drug-micelle partitioning rates. This approach improves pharmacokinetic predictions for oral drug formulations, considering food effects.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Computational Chemistry
- Gastrointestinal Physiology
Background:
- Accurate prediction of oral drug absorption is crucial for effective pharmacotherapy.
- Food and formulation effects significantly influence drug bioavailability.
- Existing models often simplify drug behavior within the gastrointestinal tract.
Purpose of the Study:
- To evaluate molecular dynamics (MD) simulations as a tool for determining drug-micelle partitioning rates.
- To develop a refined mechanistic approach for modeling drug absorption considering micelle association.
- To project human oral pharmacokinetic food/formulation effects.
Main Methods:
- Utilized molecular dynamics (MD) simulations to derive drug-micelle partitioning coefficients.
- Developed a compartmental absorption model simulating drug transit through the GI tract (stomach, small intestine, colon).
- Incorporated adjustments for intestinal viscosity changes and micelle-associated vs. unbound drug.
Main Results:
- The study successfully integrated MD simulations with a compartmental absorption model.
- The approach demonstrated utility in projecting fed vs. fasted absorption ratios for various drugs.
- Findings highlight the balance between micelle solubilization and drug permeability.
Conclusions:
- MD simulations offer a valuable front-end tool for oral absorption modeling.
- The refined mechanistic approach enhances the prediction of pharmacokinetic food/formulation effects.
- This integrated method provides insights into drug behavior within the complex GI environment.
Related Concept Videos
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...